Direxion Daily S&P Biotech Bull 3X ETF
LABU
23 hedge funds and large institutions have $46.8M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 13 closing their positions.
61% more capital invested
Capital invested by funds: $29.1M → $46.8M (+$17.7M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0.07% more ownership
Funds ownership: 0.27% → 0.34% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less call options, than puts
Call options by funds: $49.1M | Put options by funds: $50.6M
23% less funds holding
Funds holding: 30 → 23 (-7)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$4.42M |
| 2 |
Jane Street
New York
|
+$3.19M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
+$2.4M |
| 4 |
OPPM
Opus Point Partners Management
New York
|
+$1.49M |
| 5 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
+$586K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.43M |
| 2 |
VF
Virtu Financial
New York
|
-$2.72M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.27M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.27M |
| 5 |
Citigroup
New York
|
-$1.16M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
G
26
Gainplan
Bloomfield Hills,
Michigan
| – | -$329K | -500 | Closed |
|
|
JC
27
JBF Capital
Aspen,
Colorado
| – | -$329K | -500 | Closed |
|
|
TSS
28
Two Sigma Securities
New York
| – | -$216K | -328 | Closed |
|
|
HF
29
HRT Financial
New York
| – | -$203K | -310 | Closed |
|
30
Walleye Trading
New York
| – | -$41.6K | -40 | Closed |
|
31
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$25K | -38 | Closed |
|
|
SWM
32
SeaCrest Wealth Management
Purchase,
New York
| – | -$8K | -13 | Closed |
|
|
CG
33
Cutler Group
San Francisco,
California
| – | -$10.4K | -10 | Closed |
|
|
FANJ
34
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$7K | -10 | Closed |
|
|
MOS
35
MGO One Seven
Beachwood,
Ohio
| – | -$6K | -10 | Closed |
|
|
KCM
36
Karp Capital Management
Sausalito,
California
| – | -$3K | -4 | Closed |
|
LABU Hedge Fund Activity: Q1 2019 in Review
23 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2019, worth a combined $46.8M — up 61% from $29.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of LABU and 6 opened new positions — a net loss of 7 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Hellman Jordan Management Company, opening a new position worth an estimated $4.42M. The largest seller was Susquehanna International Group, cutting an estimated $6.43M.
- 23 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2019, down from 30 in Q4 2018.
- Funds reported $46.8M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2019, up 61% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2019 and 13 closed out, a net change of -7 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2019 was Hellman Jordan Management Company, an estimated $4.42M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2019 was Susquehanna International Group, an estimated $6.43M sold.
Based on aggregated 13F filings for Q1 2019.